Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

“Silymarin”, a Promising Pharmacological Agent for Treatment of Diseases

Year: 1390
COI: JR_IJBMS-14-4_002
Language: EnglishView: 93
This Paper With 10 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 10 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Gholamreza Karimi - Medical Toxicology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Maryam Vahabzadeh - Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Parisa Lari - Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Marziyeh Rashedinia - Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Mohammad Moshiri - Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract:

Widespread use of herbal drugs because of their protective effects on different organs toxicity has been shown in many studies. These protective effects have been illustrated in the fields of nephrotoxicity, hepatotoxicity, viral hepatitis, cancer, in vitro fertilization, neurotoxicity, depression, lung diseases, prostate diseases etc. Silymarin has cytoprotection activities due to its antioxidant activity and radical scavenging. The possible known mechanisms of action of silymarin protection are blockade and adjustment of cell transporters, p-glycoprotein, estrogenic and nuclear receptors. Moreover, silymarin anti-inflammatory effects through reduction of TNF-a, protective effects on erythrocyte lysis and cisplatin-induced acute nephrotoxicity have been indicated in some studies. Silymarin has also inhibited apoptosis and follicular development in patients undergoing IVF. Basis on such data, silymarin can be served as a novel medication in complementary medicine.

Keywords:

Paper COI Code

This Paper COI Code is JR_IJBMS-14-4_002. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1296994/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Karimi, Gholamreza and Vahabzadeh, Maryam and Lari, Parisa and Rashedinia, Marziyeh and Moshiri, Mohammad,1390,“Silymarin”, a Promising Pharmacological Agent for Treatment of Diseases,https://civilica.com/doc/1296994

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • Kren V, Walterova D. Silybin and Silymarin - New effects ...
  • Dermarderosin A. The review of natural products. ۱st ed. United ...
  • Mayer KE, Mayer RP, Lee SS. Silymarin treatment of viral ...
  • Saller R, Melzer J, Reichling J, Brignoli R, Meier R. ...
  • Cesanow N, Fleminh H, Kelly GA. PDR for nonprescription drugs, ...
  • Kaur M, Agarwal R. Silymarin and epithelial cancer chemoprevention: How ...
  • Karimi G, Ramezani M, Tahoonian Z. Cisplatin nephrotoxicity and protection ...
  • Basiglio CL, Sanchez Pozzi EJ, Mottino AD, Roma MG. Differential ...
  • Gazak R, Walterova D, Kren V. Silybin and silymarin - ...
  • Ramakrishnan G, Lo Muzio L, Elinos-Baez CM, Jagan S, Augustine ...
  • Toklu HZ, Tunali-Akbay T, Erkanli G, Yuksel M, Ercan F, ...
  • Eminzade S, Uraz F, Izzettin FV. Silymarin protects liver against ...
  • Katiyar SK, Roy AM, Baliga MS. Silymarin induces apoptosis primarily ...
  • Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component ...
  • Morishima C , Shuhart MC, Wang CC, Paschal DM, Apodaca ...
  • Song Z, Song M, Lee DYW, Liu Y, Deaciuc IV, ...
  • Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component ...
  • Upadhyay G, Tiwari MN, Prakash O, Jyoti A, Shanker R, ...
  • Polyak SJ, Morishima C, Shuhart MC. Inhibition of T-cell inflammatory ...
  • Ahmed-Belkacem A, Ahnou N, Barbotte L, Wychowski C, Pallier C, ...
  • Miranda SR, Jin KL, Brouwer KLR, Wen Z, Smith PC, ...
  • Pradeep K, Mohan CVR, Gobianand K, Karthikeyan S. Silymarin: An ...
  • Stickel F, Schuppan D. Herbal medicine in the treatment of ...
  • Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, ...
  • Saller R, Meier R, Brignoli R. The use of silymarin ...
  • Tyagi AK , Agarwal C, Chan DC, Agarwal R. Synergistic ...
  • Tyagi A, Agarwal C, Harrison G, Glode L M, Agarwal ...
  • Chu SC, Chiou HL, Chen PN, Yang SF, Hsieh YS. ...
  • Lahiri-Chatterjee M, Katiyar SK, Mohan RR, Agarwal R. A flavonoid ...
  • Deep G, Singh RP, Agarwal C, Kroll DJ , Agarwal ...
  • Thelen P, Jarry H, Ringert RH, Wuttke W. Silybinin down-regulates ...
  • Rana P, Agarwal S, Agarwal R. Prostate cancer chemoprevention by ...
  • Li LH, Wu LJ, Jiang YY, Tashiro S, Onodera S, ...
  • Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. ...
  • Szkudelski T. The mechanism of alloxan and streptozocin action in ...
  • Sha S, Baliga R, Rajapurkar M, Fonseca V. Oxidants in ...
  • Soto C, Mena R, Luna J, Cerbon M, Larrieta E, ...
  • Soto C, Perez J, Garcia V, Uria E, Vadillo M, ...
  • Varzi HN, Esmailzadeh S, Morovvati H, Avizeh R, Shahriari A, ...
  • Karimi G, Ramezani M, Tahoonian Z. Cisplatin nephrotoxicity and protection ...
  • Karimi G, Fallah Huseini H, Ramezani M, Tahoonian Z. Protective ...
  • Kaur G, Athar M, Alam MS. Dietary supplementation of silymarin ...
  • Nazemian F, Karimi GH, Moatamedi M, Charkazi S, Shamsara J, ...
  • Galhardi F, Mesquita K, Monserrat JM, Barros DM. Effect of ...
  • Nencini C, Giorgi G, Micheli L. Protective effect of silymarin ...
  • Davies K J. Oxidative stress, antioxidant defenses, and damage removal, ...
  • Metodiewa D, Koska C. Reactive oxygen species and reactive nitrogen ...
  • Baluchnejadmojarad T, Roghani M, Mafakheri M. Neuroprotective effect of silymarin ...
  • Karimi G, Saradeghi Keisari M. Evaluation of antidepressant effect of ...
  • Gharagozloo M, Velardi E, Bruscoli S, Agostini M, Di Sante ...
  • Soto PC, Sanchez RM, Uria CE, Favari PL. Silymarin effect ...
  • Soto C, Recoba R, Barron H, Alvarez C, Favari L. ...
  • Karimi GH, Hassanzadeh M, Mehri S. Protective effects of Silymarin ...
  • Psotova J, Chlopcikova S, Miketova P, Hrbac J, Simanek V. ...
  • El-Shitany NA, Hegazy S, El-desoky K. Evidences for antiosteoporotic and ...
  • Kiruthiga PV, Pandian SK, Devi KP. Silymarin protects PBMC against ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 8,321
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support